This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dromard, M. Articles by Freiss, G. Search for Related Content PubMed PubMed Citation Articles by Dromard, M. Articles by Freiss, G.

The Putative Tumor Suppressor Gene PTPN13/PTPL1 Induces Apoptosis through Insulin Receptor Substrate-1 Dephosphorylation

¹ Institut National de la Santé et de la Recherche Médicale, U826, Contrôle de la Progression des Cancers Hormono-Dépendants; and ² Université Montpellier I, Montpellier, France

Requests for reprints: Gilles Freiss, Institut National de la Santé et de la Recherche Médicale, U826, Centre de Recherche en Cancérologie, CRLC Val d'Aurelle-Paul Lamarque, 34298 Montpellier, France. Phone: 33-4-67-61-24-33; Fax: 33-4-67-61-37-87; E-mail: freiss{at}montp.inserm.fr.

The protein tyrosine phosphatase (PTP) PTPL1/PTPN13 is a candidate tumor suppressor gene. Indeed, PTPL1 activity has been reported recently to be decreased through somatic mutations, allelic loss, or promoter methylation in some tumors. We showed previously that its expression was necessary for inhibition of Akt activation and induction of apoptosis by antiestrogens in breast cancer cells. Implications of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway in cancer progression are now well established, and our study was therefore designed to define whether PTPL1 is sufficient to inhibit this pathway and, if so, to identify a direct substrate of this PTP, which may trigger a proapoptotic effect. We first show by complementary approaches that PTPL1 specifically dephosphorylates insulin receptor substrate-1 (IRS-1) in vitro and in cellulo. Next, our experiments using a dominant-negative mutant and RNA interference confirm the crucial role of PTPL1 in IRS-1 dephosphorylation. Finally, we report that PTPL1 expression is sufficient to block the IRS-1/PI3K/Akt signaling pathway, to inhibit the insulin-like growth factor-I effect on cell survival, and to induce apoptosis. Altogether, these data provide the first evidence for a direct positive role of the putative tumor suppressor gene PTPL1/PTPN13 on apoptosis and identify its target in the IRS-1/PI3K/Akt signaling pathway. [Cancer Res 2007;67(14):6806–13]

This article has been cited by other articles:

				J. Shi, D.-M. Wang, C.-M. Wang, Y. Hu, A.-H. Liu, Y.-L. Zhang, B. Sun, and J.-G. Song Insulin Receptor Substrate-1 Suppresses Transforming Growth Factor-{beta}1-Mediated Epithelial-Mesenchymal Transition Cancer Res., September 15, 2009; 69(18): 7180 - 7187. [Abstract] [Full Text] [PDF]

				Y. Zhang, Y. Tu, J. Zhao, K. Chen, and C. Wu Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle J. Cell Biol., March 23, 2009; 184(6): 785 - 792. [Abstract] [Full Text] [PDF]